Methoxetamine: An early report on the motivations for use, effect profile and prevalence of use in a UK clubbing sample
- PMID: 25867295
- DOI: 10.1111/dar.12259
Methoxetamine: An early report on the motivations for use, effect profile and prevalence of use in a UK clubbing sample
Abstract
Introduction and aims: To assess the prevalence of use and subjective effect profile of methoxetamine among a group of polydrug users.
Design and methods: Cross-sectional, anonymous, online survey of UK-based polydrug users was conducted. Prevalence of lifetime, last year and last month use, sourcing of the drugs, motivations for use, and subjective effect and risk profile compared with that of ketamine were measured.
Results: There were 7700 UK-based polydrug users, of whom 326 reported recent use of methoxetamine. Of the whole sample, 4.2% reported last 12 month use of methoxetamine compared with 24.5% for ketamine. The most common route of use was intranasal and the predominate effect described as psychedelic. Of the 15.5% of last year users of ketamine reporting last year use of methoxetamine, only 18.7% reported that they thought methoxetamine was less damaging to their kidneys or bladder than ketamine. Its broad effect profile, based on participants' first experience of use, was very similar to that of ketamine. Almost one-third of users reported that they did not intend to try the drug again.
Discussion and conclusions: Methoxetamine appears to have a broadly similar effect profile to that of ketamine. Only a minority of participants were motivated to use it because they believed it was less damaging to their kidneys or bladder than ketamine. The impact of the recent temporary banning order on availability and use of both methoxetamine and ketamine should be monitored carefully.
Keywords: ketamine; methoxetamine; monitoring system; novel psychoactive substance.
© 2015 Australasian Professional Society on Alcohol and other Drugs.
Similar articles
-
Methoxetamine--a novel recreational drug with potent hallucinogenic properties.Toxicol Lett. 2014 Nov 4;230(3):402-7. doi: 10.1016/j.toxlet.2014.08.011. Epub 2014 Aug 13. Toxicol Lett. 2014. PMID: 25128700 Review.
-
Phenomenon of new drugs on the Internet: the case of ketamine derivative methoxetamine.Hum Psychopharmacol. 2012 Mar;27(2):145-9. doi: 10.1002/hup.1242. Hum Psychopharmacol. 2012. PMID: 22389078 Review.
-
Methoxetamine misuse and toxicity.J Stud Alcohol Drugs. 2013 Sep;74(5):816-7. doi: 10.15288/jsad.2013.74.816. J Stud Alcohol Drugs. 2013. PMID: 23948543 No abstract available.
-
The ketamine analog methoxetamine: a new designer drug to threaten military readiness.Mil Med. 2014 Oct;179(10):1149-57. doi: 10.7205/MILMED-D-13-00470. Mil Med. 2014. PMID: 25269134 Review.
-
Acute toxicity associated with the recreational use of the ketamine derivative methoxetamine.Eur J Clin Pharmacol. 2012 May;68(5):853-6. doi: 10.1007/s00228-011-1199-9. Epub 2011 Dec 29. Eur J Clin Pharmacol. 2012. PMID: 22205276
Cited by
-
Trends in drug use among nightclub and festival attendees in New York City, 2017-2022.Int J Drug Policy. 2023 May;115:104001. doi: 10.1016/j.drugpo.2023.104001. Epub 2023 Mar 17. Int J Drug Policy. 2023. PMID: 36934660 Free PMC article.
-
Interpol review of controlled substances 2016-2019.Forensic Sci Int Synerg. 2020 May 24;2:608-669. doi: 10.1016/j.fsisyn.2020.01.019. eCollection 2020. Forensic Sci Int Synerg. 2020. PMID: 33385148 Free PMC article. Review.
-
When good times go bad: managing 'legal high' complications in the emergency department.Open Access Emerg Med. 2017 Dec 20;10:9-23. doi: 10.2147/OAEM.S120120. eCollection 2018. Open Access Emerg Med. 2017. PMID: 29302196 Free PMC article. Review.
-
Moving on From Representativeness: Testing the Utility of the Global Drug Survey.Subst Abuse. 2017 Jun 30;11:1178221817716391. doi: 10.1177/1178221817716391. eCollection 2017. Subst Abuse. 2017. PMID: 28924351 Free PMC article.
-
Phencyclidine-like in vivo effects of methoxetamine in mice and rats.Neuropharmacology. 2018 May 15;134(Pt A):158-166. doi: 10.1016/j.neuropharm.2017.08.028. Epub 2017 Aug 19. Neuropharmacology. 2018. PMID: 28830759 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical